IFP Advisors’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCY
SI
IAIM
CCM
XT
VF
TAM
IFP Advisors's ONCY Position: Q4 2025 in Review
IFP Advisors sold out of Oncolytics Biotech (ONCY) in Q4 2025, closing a stake of 100 shares — an estimated $140 sold.
IFP Advisors first reported a position in ONCY in Q4 2019 and held it in 20 quarters. The position peaked at $19K in Q1 2021. 61 funds tracked by Wall St. Rank hold ONCY as of Q4 2025.
- IFP Advisors reported no remaining Oncolytics Biotech position as of Q4 2025 after selling out during the quarter.
- IFP Advisors sold 100 Oncolytics Biotech shares in Q4 2025, an estimated $140.
- IFP Advisors first reported a position in Oncolytics Biotech in Q4 2019 and held it in 20 quarters.
- IFP Advisors's Oncolytics Biotech position peaked at $19K in Q1 2021.
- 61 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q4 2025.
Based on IFP Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.